Tissue selectivity of insulin detemir action in vivo
Tissue selectivity of insulin detemir action in vivo
About this item
Full title
Author / Creator
HENNIGE, A. M , SARTORIUS, T , TSCHRITTER, O , PREISSL, H , FRITSCHE, A , RUTH, P and HÄRING, H.-U
Publisher
Berlin: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Berlin: Springer
Subjects
More information
Scope and Contents
Contents
Recombinant DNA technology is a useful tool that can be used to create insulin analogues with modified absorption kinetics to improve glycaemic control in patients with type 1 and type 2 diabetes. Among conventional insulin analogues, which are usually created by amino acid exchange, insulin detemir is the first analogue to be acylated with a fatty...
Alternative Titles
Full title
Tissue selectivity of insulin detemir action in vivo
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_67942090
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67942090
Other Identifiers
ISSN
0012-186X
E-ISSN
1432-0428
DOI
10.1007/s00125-006-0192-9
